Search research articles
Contact Us
Filters
Showing results (1-10 of 99) with videos related to
Page
of 10
Sort By:
Medicina Clinica
|
August 2, 2017
Approaching to DM2 through sodium-glucose cotransporter-2: does it make sense?
Julián Segura
Medicina Clinica
|
January 22, 2014
[Contribution of the kidney to glucose homeostasis]
Julián Segura, Luis Miguel Ruilope
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 1, 2002
Factors influencing the systolic blood pressure response to drug therapy
Carlos Campo, Julián Segura, Luis M Ruilope
Revista De Enfermeria (Barcelona, Spain)
|
July 4, 2006
[Chronotherapy in hypertension]
María Luisa Fernández, Lucía Guerrero, Julián Segura
Current Cardiology Reports
|
October 16, 2002
Proteinuria: an underappreciated risk factor in cardiovascular disease
Julián Segura, Carlos Campo, Luis M Ruilope
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
March 11, 2008
What Do Spanish physicians believe and expect about telemedicine? Results of a Delphi-based survey
Julián Segura, Cecilia Roldán, Jordi Galera, et al.
Journal of the American Society of Nephrology : JASN
|
June 7, 2005
Calcium channel blockers and renal protection: insights from the latest clinical trials
Julián Segura, José A García-Donaire, Luis M Ruilope
Current Opinion in Nephrology and Hypertension
|
August 19, 2007
Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
Julián Segura, José A García-Donaire, Luis M Ruilope
Expert Review of Cardiovascular Therapy
|
March 20, 2004
Renal participation in cardiovascular risk in essential hypertension
Luis M Ruilope, Julián Segura, Carlos Campo, et al.
Journal of Hypertension
|
November 5, 2005
Do we need to target 'prediabetic' hypertensive patients?
Julián Segura, Carlos Campo, Luis M Ruilope, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 99) with videos related to
Sort By:
Page
of 10
Medicina Clinica
|
August 2, 2017
Approaching to DM2 through sodium-glucose cotransporter-2: does it make sense?
Julián Segura
Medicina Clinica
|
January 22, 2014
[Contribution of the kidney to glucose homeostasis]
Julián Segura, Luis Miguel Ruilope
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 1, 2002
Factors influencing the systolic blood pressure response to drug therapy
Carlos Campo, Julián Segura, Luis M Ruilope
Revista De Enfermeria (Barcelona, Spain)
|
July 4, 2006
[Chronotherapy in hypertension]
María Luisa Fernández, Lucía Guerrero, Julián Segura
Current Cardiology Reports
|
October 16, 2002
Proteinuria: an underappreciated risk factor in cardiovascular disease
Julián Segura, Carlos Campo, Luis M Ruilope
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
March 11, 2008
What Do Spanish physicians believe and expect about telemedicine? Results of a Delphi-based survey
Julián Segura, Cecilia Roldán, Jordi Galera, et al.
Journal of the American Society of Nephrology : JASN
|
June 7, 2005
Calcium channel blockers and renal protection: insights from the latest clinical trials
Julián Segura, José A García-Donaire, Luis M Ruilope
Current Opinion in Nephrology and Hypertension
|
August 19, 2007
Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
Julián Segura, José A García-Donaire, Luis M Ruilope
Expert Review of Cardiovascular Therapy
|
March 20, 2004
Renal participation in cardiovascular risk in essential hypertension
Luis M Ruilope, Julián Segura, Carlos Campo, et al.
Journal of Hypertension
|
November 5, 2005
Do we need to target 'prediabetic' hypertensive patients?
Julián Segura, Carlos Campo, Luis M Ruilope, et al.
Page
of 10